ArticleBMC public health2025
Perception of healthcare professionals about the knowledge of people living with HIV regarding clinical trials for HIV-related cancers.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAdvances in HIV treatments have prolonged the lifespan of people living with HIV (PLWH), thereby increasing the risk of chronic conditions such as HIV-related cancers. Clinical trials (CT) play an important role in advancing cancer care in PLWH. However, their underrepresentation in CT underscores the need for involvement of healthcare professionals in CT referrals. This study aims to describe healthcare professionals' perception of PLWH understanding of CT for HIV-related cancers.
methodsWe analyzed survey data from a training activity provided to healthcare professionals (n = 82) from HIV-specialized clinics and other healthcare organizations in Puerto Rico to assess healthcare professionals' perception of PLWH knowledge regarding CT for HIV-related cancers.
resultsMost participants were allied healthcare professionals (39.0%) or social services professionals (43.9%), with 70.8% having 1-15 years of experience caring for PLWH. Most participants believed that PLWH had limited knowledge about HIV-related cancers (65.8%) and CT for these cancers (59.8%). Nearly a quarter (23.1%) of healthcare professionals reported hearing expressions of fear regarding CT from PLWH. Conversely, almost half (49.4%) heard positive comments or experiences about participating in CT. The training activity did not include physicians. Perceived barriers for participation of PLWH in CT, according to the healthcare professionals, included fear of the unknown (48.8%), stigma associated with the participation in HIV-related clinical trials (43.9%), and lack of knowledge (42.7%).
conclusionsAccording to healthcare professionals, the participation of PLWH in HIV-related clinical trials could be affected by limited knowledge or awareness about their benefits. Training activities are needed to increase awareness, knowledge and improve the participation of PLWH in HIV-related CT. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.